Drugs / VR506
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2/3 | NCT01720069 Comparator | Oct 2012 → Oct 2013 | asthma | Vectura Limited | Completed | No outcome recorded |
| Phase 2/3 | NCT01472757 Comparator | Oct 2011 → May 2013 | asthma | Vectura Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VR506 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01472757 ↗ |
| Route | Inhaled | “VR506 inhalation powder delivered via a new dry powder inhaler” NCT01472757 ↗ |